Peptide record

TPDB64758

AP9 Blood-Brain Barrier modified_plain modified
9 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB64758
AP9
Blood-Brain Barrier
Delivery and barrier-penetrating peptides
B3Pred BBPpredict Peptipedia
modified_plain
Yes
A 9-aa modified blood-brain barrier peptide sequence curated from B3Pred, BBPpredict, and Peptipedia, with an available 3D structural model.
C-terminal: C-terminal amidation
Sequence
NPNDKYEPF
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
9 reviewed residue count
C-terminal amidation Activity
Linear Activity
Evidence Records 1 records
Evidence 1 Activity

Activity

Blood-Brain Barrier

Assay & Model

20 mg/kg
Evans blue dye
The preservation of the protective effect of double AP9 administration in the postischemic period.
Photothrombosis - induced ischemia

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Intravenous
It induce β-arrestin-2-dependent cytoprotective pathways.
Alone
Additional Detail Fields 1 fields
Intravenous